SureTrader Stock Hero Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator, KingDMC
Search This Board:
Last Post: 5/1/2015 7:40:02 PM - Followers: 386 - Board type: Free - Posts Today: 0

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
INO News: Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers 12/18/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology 12/17/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 12/15/2014 08:00:00 AM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#12936   Fwiw I just got in this as a pfc0789 05/01/15 07:40:02 PM
#12935   FWIW - I've been in this at $1.10, nanopatent 04/30/15 05:48:24 PM
#12934   Good. nanopatent 04/30/15 05:45:13 PM
#12933   Doesnt matter, this future not 50 pps next harry crumb 04/30/15 04:12:45 PM
#12932   Im not dreaming at all, 600$ nah, 50-60 harry crumb 04/30/15 04:09:06 PM
#12931   But I am dreaming like those who believe kpisme 04/30/15 03:25:38 PM
#12930   Should be and would be if market confidence ppnlf 04/30/15 02:46:32 PM
#12929   Would not the $76 million from this underwriting nanopatent 04/30/15 02:39:00 PM
#12928   And when we break support at $8 we ppnlf 04/30/15 02:34:51 PM
#12927   A look at the brighter side.... For INO CCruzNY 04/30/15 01:39:31 PM
#12926   Be reasonable - GOOG is ~ $600. nanopatent 04/30/15 01:39:29 PM
#12925   I guess the only consolation in today's sorry ppnlf 04/30/15 01:28:47 PM
#12924   Why stop there with the dreaming A million kpisme 04/30/15 12:31:12 PM
#12923   $20? This INO is the Google of biotech. nanopatent 04/30/15 10:13:52 AM
#12922   Agree, thinking its Ebola trial or a P3 Tate 04/30/15 09:49:01 AM
#12921   I'm a big believer in DR Kim since KingDMC 04/30/15 09:46:23 AM
#12920   Yeah, whatever! kpisme 04/30/15 09:40:24 AM
#12919   Seen that now. Given the market cap of ppnlf 04/30/15 09:28:44 AM
#12918   Because they are raising $76M! Great things happening Tate 04/30/15 09:20:51 AM
#12917   Why is the PM price drop so large? ppnlf 04/30/15 09:14:09 AM
#12916   What a golden oppertunity to add! People, use harry crumb 04/29/15 04:57:58 PM
#12915   Inovio Initiates Equity offering... CCruzNY 04/29/15 04:32:52 PM
#12914   Here is another abstract in for May biovalidator 04/28/15 11:13:45 AM
#12913   Thanks Bio......I was just about to post the johan31 04/27/15 10:41:29 PM
#12912   American Society of Gene & Cell Therapy: ASGCT biovalidator 04/27/15 09:38:31 PM
#12911   Very nice. Dr Kim good man! KingDMC 04/21/15 07:10:34 AM
#12910   Inovio Pharmaceuticals and Roche Initiate Clinical Trial for Fsa888 04/21/15 03:27:33 AM
#12909   Up to now cancer was treated by cutting nanopatent 04/16/15 04:24:06 PM
#12908   Inovio working on man-made DNA solutions to Ebola, MRatt 04/16/15 01:37:29 PM
#12907   INO Stock – A Cure for Cancer? Inovio nanopatent 04/15/15 09:11:12 PM
#12906   Inovio Pharmaceuticals (NASDAQ:INO) Director Angel Cabrera purchased 8,000 nanopatent 04/15/15 01:52:28 PM
#12905   Nice outlook! harry crumb 04/14/15 07:01:31 PM
#12904   I could see this at 18 area in harry crumb 04/14/15 07:00:59 PM
#12903   Remember the old saw - like printing money? nanopatent 04/14/15 03:57:52 PM
#12902   $INO KingDMC 04/14/15 12:27:58 PM
#12901   Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given a $20.666 Price nanopatent 04/14/15 09:58:03 AM
#12900   Did you read some of the comments? Ridiculous. Perkin78 04/13/15 10:04:52 AM
#12899   Scientists Create Man-Made DNA That Mimics Killer Diseases, nanopatent 04/12/15 09:57:30 AM
#12898   Saw this article posted today by the Daily inveterate 04/12/15 08:28:09 AM
#12897   Me too. My RS split-adjusted shares are @ north40000 04/09/15 12:56:18 PM
#12896   Thank you---very informative. north40000 04/09/15 12:37:41 PM
#12895   Nice article to provide another catalyst further down harry crumb 04/09/15 08:51:13 AM
#12894   Cabilly patents 1, 2, & 3 do not johan31 04/09/15 08:34:23 AM
#12893   Been a believer in Dr Kim since well KingDMC 04/09/15 08:03:53 AM
#12892   Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo KingDMC 04/09/15 08:03:19 AM
#12891   Nice ah action tonite. 11's possible tomorrow?? harry crumb 04/08/15 10:54:30 PM
#12890   In at $1 and looking for $10. nanopatent 04/08/15 06:25:01 PM
#12889   Escape Roche/DNA Cabilly patent? Does INO currently use north40000 04/08/15 06:16:19 PM
#12888   Largest grant ever for studying ebola. But the johan31 04/08/15 05:59:58 PM
#12887   Dr. Kim to be interviewed on CNBC NOW.Contract north40000 04/08/15 05:44:31 PM